can tirzepatide cause gout GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds GLP-1 Medications and Gout Risk:

Understanding Semaglutide and Its Role in Weight Management Semaglutide is an FDA-approved medication specifically designed for chronic weight management in adults with obesity or those who are overweight with accompanying weight-related conditions

Colyer S

New neurological symptoms

Important cardiovascular considerations include: Potential to improve blood pressure and other metabolic markers

The metabolic syndrome is a group of metabolic dysfunctional features, including abdominal obesity, insulin resistance, hyperglycemia due to impaired glucose metabolism, high blood pressure, and abnormal blood lipid levels

The effect of glucagon-like peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients